Ferndale Pharmaceuticals (Quinoderm & Ceanel brands) is Personal Products in United Kingdom that focus on topical therapeutic products business. Founded in 2003. They cover business area such as provider, skincare, therapeutic product, skin care medication, acne, scalp therapy treatment.
2003
( 21 years old in 2024 )
Topical Therapeutic Products
-
Unit 740
Thorp Arch Estate
Wetherby LS23 7FX
England, United Kingdom
Private
providerskincaretherapeutic productskin care medicationacnescalp therapy treatment
* We use standard office opening hours in near Ferndale Pharmaceuticals (Quinoderm & Ceanel brands)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Ferndale Pharmaceuticals (Quinoderm & Ceanel Brands) is Personal Products business from United Kingdom that founded in 2003 (21 years old in 2024), Ferndale Pharmaceuticals (Quinoderm & Ceanel brands) business is focusing on Topical Therapeutic Products.
Ferndale Pharmaceuticals (Quinoderm & Ceanel brands) headquarter office and corporate office address is located in Unit 740 Thorp Arch Estate Wetherby LS23 7FX England, United Kingdom.
Ferndale Pharmaceuticals (Quinoderm & Ceanel brands) was founded in United Kingdom.
In 2024, Ferndale Pharmaceuticals (Quinoderm & Ceanel brands) is currently focus on topical therapeutic products sector.
Above is snippet of Google Trends for "topical therapeutic products" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Ferndale Pharmaceuticals (Quinoderm & Ceanel brands), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
